4/22
08:07 am
vvos
Vivos Therapeutics (VVOS) had its price target lowered by Ascendiant Capital Markets from $5.50 to $3.00. They now have a "buy" rating on the stock.
Low
Report
Vivos Therapeutics (VVOS) had its price target lowered by Ascendiant Capital Markets from $5.50 to $3.00. They now have a "buy" rating on the stock.
4/22
06:09 am
vvos
Vivos Therapeutics (VVOS) had its "sell (e+)" rating reaffirmed by
Weiss Ratings .
Low
Report
Vivos Therapeutics (VVOS) had its "sell (e+)" rating reaffirmed by
Weiss Ratings .
4/17
10:56 am
vvos
Vivos Therapeutics (VVOS) had its price target lowered by HC Wainwright from $7.00 to $2.50. They now have a "buy" rating on the stock.
Medium
Report
Vivos Therapeutics (VVOS) had its price target lowered by HC Wainwright from $7.00 to $2.50. They now have a "buy" rating on the stock.
4/16
03:11 am
vvos
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... [Yahoo! Finance]
High
Report
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... [Yahoo! Finance]
4/15
08:12 pm
vvos
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call [Yahoo! Finance]
High
Report
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call [Yahoo! Finance]
4/15
05:38 pm
vvos
Vivos Therapeutics Reports Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
Vivos Therapeutics Reports Full Year 2025 Financial Results [Yahoo! Finance]
4/15
04:20 pm
vvos
Vivos Therapeutics Reports Full Year 2025 Financial Results
High
Report
Vivos Therapeutics Reports Full Year 2025 Financial Results
4/15
08:45 am
vvos
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
High
Report
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
11/19/2025
04:20 pm
vvos
vivos therapeutics, inc.
BEAT
Report
-11.3%
vivos therapeutics, inc.
5/15/2025
04:20 pm
vvos
vivos therapeutics, inc.
MISS
Report
-13.0%
vivos therapeutics, inc.
4/22
04:25 pm
vvos
Form 8-K Vivos Therapeutics, Inc. For: Apr 22
High
Report
Form 8-K Vivos Therapeutics, Inc. For: Apr 22
4/15
05:15 pm
vvos
Form 8-K Vivos Therapeutics, Inc. For: Apr 15
High
Report
Form 8-K Vivos Therapeutics, Inc. For: Apr 15
4/15
05:01 pm
vvos
Form 10-K Vivos Therapeutics, Inc. For: Dec 31
High
Report
Form 10-K Vivos Therapeutics, Inc. For: Dec 31
4/10
04:54 pm
vvos
Form 3 Vivos Therapeutics, Inc. For: Mar 31 Filed by: V-Co Investors 3 LLC
Medium
Report
Form 3 Vivos Therapeutics, Inc. For: Mar 31 Filed by: V-Co Investors 3 LLC
4/3
04:06 pm
vvos
Form 8-K Vivos Therapeutics, Inc. For: Apr 03
High
Report
Form 8-K Vivos Therapeutics, Inc. For: Apr 03
4/2
07:34 pm
vvos
Form 4 Vivos Therapeutics, Inc. For: Mar 31 Filed by: Skaff Michael C
Low
Report
Form 4 Vivos Therapeutics, Inc. For: Mar 31 Filed by: Skaff Michael C
4/2
06:33 pm
vvos
Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 3 LLC
Low
Report
Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 3 LLC
3/31
04:02 pm
vvos
Form NT 10-K Vivos Therapeutics, Inc. For: Dec 31
High
Report
Form NT 10-K Vivos Therapeutics, Inc. For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register